Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ring Opening. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102174006A details a novel chiral hydroxyl amide synthesis using copper acetate, offering high conversion rates for pharmaceutical intermediate manufacturing.
Patent CN110256247B reveals a high-yield, room-temperature synthesis of fluorene intermediates using trifluoromethanesulfonic acid, offering significant cost and supply chain advantages.
Novel one-pot method for Vilanterol intermediate fumarate. Reduces solvent waste, improves purity to >99.8%, and ensures scalable supply chain reliability for global pharma partners.
Patent CN115417783A details a novel route for oseltamivir enantiomers, offering high purity and scalable manufacturing for global antiviral supply chains.
Patent CN108047118A reveals a green, metal-free route for high-purity 3-indoleselenyl alcohol intermediates, offering substantial cost and supply chain advantages.
Novel oxidation method for high-purity intermediates. Cost-effective, scalable synthesis for pharma and agrochemical applications using air atmosphere.
Patent CN111875520A reveals a salt-free synthesis route for Atorvastatin intermediates, offering high purity and reduced environmental costs for pharmaceutical manufacturers.
Patent CN101153030B details a novel photochemical route from abundant triterpenoids to chiral decalin intermediates, offering significant cost reduction and supply chain stability for fragrance and pharmaceutical manufacturing.
Novel ZnO-catalyzed route offers high-purity Lumefantrine Impurity I. Simplified process ensures cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patented route for high-purity nucleoside intermediates. Enhances solubility and yield for nucleic acid drug manufacturing supply chains.
Novel resolution process for chiral piperidine intermediates. Reduces steps and cost for pharmaceutical manufacturing. Reliable supply chain partner.
Novel 9,11-epoxy route reduces steps and cost for fluorometholone manufacturing. Reliable supplier for high-purity steroid intermediates.
Patent CN100408555C reveals a high-yield synthesis of 4-chloro-3-hydroxybutyronitrile using basic catalysts, offering significant cost reduction and waste minimization for supply chains.
Novel green route for Sonidegib intermediates via epoxide ring-opening. Eliminates expensive chiral starting materials and reduces wastewater for cost-effective manufacturing.
Patent CN103613557B reveals mild condition synthesis for gadobutrol. Enhances purity and supply chain stability for pharmaceutical intermediate manufacturing globally.
Patent CN103319482B enables mild synthesis of pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN101633647B details a novel four-step synthesis for alpha-azyl aryl alkyl ketones, offering superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN117700371B enables high-purity pharmaceutical intermediate production with improved yield and safety for global supply chains.
Patent CN114671849B discloses a mild ring-opening method for glucopyranosides, offering high yields and environmental benefits for reliable pharmaceutical intermediate suppliers.
Novel Lewis acid catalyzed route for Brivaracetam intermediate. High purity, scalable process avoiding hazardous halogenation for reliable supply.